Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-17-056529

SVP & Chief Scientific Officer sold 43,677 shares at $24.97 ($1,090,615)

  • SVP & Chief Scientific Officer acquired 43,677 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Doberstein Stephen K SVP & Chief Scientific Officer 2017-10-05 Option exercise +43,677 $9.53 $416,242 74,779 D
Doberstein Stephen K SVP & Chief Scientific Officer 2017-10-05 Sale −43,677 $24.97 $1,090,615 31,102 D
Derivatives
Doberstein Stephen K SVP & Chief Scientific Officer 2017-10-05 Option exercise · Stock Option −43,677 396,323 D
Open-market sales · 43,677 sh · avg $24.97 · $1,090,615
Loading xslF345X03/doc4.xml…